🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
The purpose of this study is to see whether combination treatment of Teclis...
Status
Recruiting
Location
University of Miami
Start Date
2023-12-04
Trial ID
NCT06100237
Treatments Being Tested
This is an open - label study to evaluate the safety, pharmacokinetics, pha...
Status
Recruiting
Location
Children's Hospital, Zhejiang University School of Medicine
Start Date
2025-08-25
Trial ID
NCT07087314
Treatments Being Tested
Primary Objectives: * VCDI cohort: * To determine the maximum tolerated...
Status
Completed
Location
Investigational Site Number : 250002
Start Date
2015-09-30
Trial ID
NCT02513186
Treatments Being Tested
Multiple myeloma (MM) is a plasma cell disease characterized by the growth ...
Status
Active Not Recruiting
Location
Stanford University School of Med /ID# 242809
Start Date
2022-05-17
Trial ID
NCT05308654
Treatments Being Tested
Multiple myeloma (MM) is a plasma cell malignancy characterized by the prol...
Status
Not Yet Recruiting
Location
University of Arizona Cancer Center /ID# 285339
Start Date
2026-11-30
Trial ID
NCT07728188
Treatments Being Tested
The purpose of this study is to evaluate the tolerability and safety of sub...
Status
Completed
Location
National Hospital Organization Shibukawa Medical Center
Start Date
2017-08-10
Trial ID
NCT03242889
Treatments Being Tested
This study is a Phase Ib, open label, single arm, adaptive multi-centre cli...
Status
Active Not Recruiting
Location
Cork University Hospital
Start Date
2021-12-08
Trial ID
NCT04667663
Treatments Being Tested
To evaluate the safety and efficacy of Anti-CD38 Antibody in the treatment ...
Status
Recruiting
Location
Chinese Academy of Medical Science and Blood Disease Hospital
Start Date
2025-08
Trial ID
NCT07063199
Treatments Being Tested
Lenalidomide is a standard of care for maintenance therapy after autologous...
Status
Not Yet Recruiting
Location
CHU Angers
Start Date
2025-05-01
Trial ID
NCT06931704
Treatments Being Tested